These results suggest that NK cell depletion and CD40L blockade target a common pathway that results in diminished T cell differentiation and that the effect of NK cells on T cell differentiation in the TDLN during early-stage tumor growth is via CD40L. This evidence concerns the gene CD40LG and neoplasm.